These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
169 related articles for article (PubMed ID: 34458258)
1. Partial Inhibition of the 6-Phosphofructo-2-Kinase/Fructose-2,6-Bisphosphatase-3 (PFKFB3) Enzyme in Myeloid Cells Does Not Affect Atherosclerosis. Tillie RJHA; De Bruijn J; Perales-Patón J; Temmerman L; Ghosheh Y; Van Kuijk K; Gijbels MJ; Carmeliet P; Ley K; Saez-Rodriguez J; Sluimer JC Front Cell Dev Biol; 2021; 9():695684. PubMed ID: 34458258 [TBL] [Abstract][Full Text] [Related]
2. Inhibition of PFKFB3 Hampers the Progression of Atherosclerosis and Promotes Plaque Stability. Poels K; Schnitzler JG; Waissi F; Levels JHM; Stroes ESG; Daemen MJAP; Lutgens E; Pennekamp AM; De Kleijn DPV; Seijkens TTP; Kroon J Front Cell Dev Biol; 2020; 8():581641. PubMed ID: 33282864 [TBL] [Abstract][Full Text] [Related]
3. PFKFB3 gene deletion in endothelial cells inhibits intraplaque angiogenesis and lesion formation in a murine model of venous bypass grafting. Perrotta P; de Vries MR; Peeters B; Guns PJ; De Meyer GRY; Quax PHA; Martinet W Angiogenesis; 2022 Feb; 25(1):129-143. PubMed ID: 34432198 [TBL] [Abstract][Full Text] [Related]
4. Mice with a specific deficiency of Pfkfb3 in myeloid cells are protected from hypoxia-induced pulmonary hypertension. Wang L; Zhang X; Cao Y; Ma Q; Mao X; Xu J; Yang Q; Zhou Y; Lucas R; Fulton DJ; Su Y; Barman SA; Hong M; Liu Z; Huo Y Br J Pharmacol; 2021 Mar; 178(5):1055-1072. PubMed ID: 33300142 [TBL] [Abstract][Full Text] [Related]
5. Neutrophil-specific STAT4 deficiency attenuates atherosclerotic burden and improves plaque stability via reduction in neutrophil activation and recruitment into aortas of Keeter WC; Moriarty AK; Akers R; Ma S; Mussbacher M; Nadler JL; Galkina EV Front Cardiovasc Med; 2023; 10():1175673. PubMed ID: 37396582 [TBL] [Abstract][Full Text] [Related]
6. Neutrophil-specific STAT4 deficiency attenuates atherosclerotic burden and improves plaque stability via reduction in neutrophil activation and recruitment into aortas of Keeter WC; Moriarty AK; Akers R; Ma S; Mussbacher M; Nadler JL; Galkina EV bioRxiv; 2023 Feb; ():. PubMed ID: 36865098 [TBL] [Abstract][Full Text] [Related]
7. Deficiency of Myeloid Pfkfb3 Protects Mice From Lung Edema and Cardiac Dysfunction in LPS-Induced Endotoxemia. Xu J; Wang L; Yang Q; Ma Q; Zhou Y; Cai Y; Mao X; Da Q; Lu T; Su Y; Bagi Z; Lucas R; Liu Z; Hong M; Ouyang K; Huo Y Front Cardiovasc Med; 2021; 8():745810. PubMed ID: 34660743 [TBL] [Abstract][Full Text] [Related]
8. Genomic Deletion of PFKFB3 Decreases In Vivo Tumorigenesis. Imbert-Fernandez Y; Chang SM; Lanceta L; Sanders NM; Chesney J; Clem BF; Telang S Cancers (Basel); 2024 Jun; 16(13):. PubMed ID: 39001392 [TBL] [Abstract][Full Text] [Related]
9. Increased 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase-3 activity in response to EGFR signaling contributes to non-small cell lung cancer cell survival. Lypova N; Telang S; Chesney J; Imbert-Fernandez Y J Biol Chem; 2019 Jul; 294(27):10530-10543. PubMed ID: 31126985 [TBL] [Abstract][Full Text] [Related]
10. Zhx2 Accelerates Sepsis by Promoting Macrophage Glycolysis via Pfkfb3. Wang Z; Kong L; Tan S; Zhang Y; Song X; Wang T; Lin Q; Wu Z; Xiang P; Li C; Gao L; Liang X; Ma C J Immunol; 2020 Apr; 204(8):2232-2241. PubMed ID: 32179636 [TBL] [Abstract][Full Text] [Related]
11. Phosphorylation of the 6-phosphofructo-2-kinase/fructose 2,6-bisphosphatase/PFKFB3 family of glycolytic regulators in human cancer. Bando H; Atsumi T; Nishio T; Niwa H; Mishima S; Shimizu C; Yoshioka N; Bucala R; Koike T Clin Cancer Res; 2005 Aug; 11(16):5784-92. PubMed ID: 16115917 [TBL] [Abstract][Full Text] [Related]
12. Gene-dosage effect of Pfkfb3 on monocyte/macrophage biology in atherosclerosis. Guo S; Li A; Fu X; Li Z; Cao K; Song M; Huang S; Li Z; Yan J; Wang L; Dai X; Feng D; Wang Y; He J; Huo Y; Xu Y Br J Pharmacol; 2022 Nov; 179(21):4974-4991. PubMed ID: 35834356 [TBL] [Abstract][Full Text] [Related]
13. Small molecule 3PO inhibits glycolysis but does not bind to 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase-3 (PFKFB3). Emini Veseli B; Perrotta P; Van Wielendaele P; Lambeir AM; Abdali A; Bellosta S; Monaco G; Bultynck G; Martinet W; De Meyer GRY FEBS Lett; 2020 Sep; 594(18):3067-3075. PubMed ID: 32620030 [TBL] [Abstract][Full Text] [Related]
14. Deficiency of myeloid PHD proteins aggravates atherogenesis via macrophage apoptosis and paracrine fibrotic signalling. van Kuijk K; Demandt JAF; Perales-Patón J; Theelen TL; Kuppe C; Marsch E; de Bruijn J; Jin H; Gijbels MJ; Matic L; Mees BME; Reutelingsperger CPM; Hedin U; Biessen EAL; Carmeliet P; Baker AH; Kramann RK; Schurgers LJ; Saez-Rodriguez J; Sluimer JC Cardiovasc Res; 2022 Mar; 118(5):1232-1246. PubMed ID: 33913468 [TBL] [Abstract][Full Text] [Related]
15. Myeloid PFKFB3-mediated glycolysis promotes kidney fibrosis. Yang Q; Huo E; Cai Y; Zhang Z; Dong C; Asara JM; Shi H; Wei Q Front Immunol; 2023; 14():1259434. PubMed ID: 38035106 [TBL] [Abstract][Full Text] [Related]
16. Role of PFKFB3-driven glycolysis in sepsis. Xiao M; Liu D; Xu Y; Mao W; Li W Ann Med; 2023 Dec; 55(1):1278-1289. PubMed ID: 37199341 [TBL] [Abstract][Full Text] [Related]
17. Increased stromal PFKFB3-mediated glycolysis in inflammatory bowel disease contributes to intestinal inflammation. Zhou Z; Plug LG; Patente TA; de Jonge-Muller ESM; Elmagd AA; van der Meulen-de Jong AE; Everts B; Barnhoorn MC; Hawinkels LJAC Front Immunol; 2022; 13():966067. PubMed ID: 36405760 [TBL] [Abstract][Full Text] [Related]
18. Inhibition of 6-phosphofructo-2-kinase (PFKFB3) suppresses glucose metabolism and the growth of HER2+ breast cancer. O'Neal J; Clem A; Reynolds L; Dougherty S; Imbert-Fernandez Y; Telang S; Chesney J; Clem BF Breast Cancer Res Treat; 2016 Nov; 160(1):29-40. PubMed ID: 27613609 [TBL] [Abstract][Full Text] [Related]
19. Expression of inducible 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase/PFKFB3 isoforms in adipocytes and their potential role in glycolytic regulation. Atsumi T; Nishio T; Niwa H; Takeuchi J; Bando H; Shimizu C; Yoshioka N; Bucala R; Koike T Diabetes; 2005 Dec; 54(12):3349-57. PubMed ID: 16306349 [TBL] [Abstract][Full Text] [Related]
20. CPEB4 Increases Expression of PFKFB3 to Induce Glycolysis and Activate Mouse and Human Hepatic Stellate Cells, Promoting Liver Fibrosis. Mejias M; Gallego J; Naranjo-Suarez S; Ramirez M; Pell N; Manzano A; Suñer C; Bartrons R; Mendez R; Fernandez M Gastroenterology; 2020 Jul; 159(1):273-288. PubMed ID: 32169429 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]